References

Trichophyton indotineae, from epidemiology to therapeutic

10.1016/j.mycmed.2023.101383 · 2023 · External reference

Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic

10.1111/jdv.17241 · 2021 · External reference

Antifungal resistance of the Trichophyton mentagrophytes/Trichophyton interdigitale species complex: insights from the China antifungal Resistance Dermatophytes Surveillance network Study (CARDS)

10.1111/jdv.20752 · 2026 · External reference

Clinico‐mycological and therapeutic updates on cutaneous dermatophytic infections in the era of Trichophyton indotineae

10.1016/j.jaad.2024.03.024 · 2024 · External reference

Emerging terbinafine‐resistant Trichophyton indotineae between 2018 and 2023: a multinational genomic epidemiology study

10.1016/j.lanmic.2025.101273 · 2026 · External reference

‘Trichophyton indotineae’ is an inaccurate and pejorative term

10.25259/ijdvl_1793_2024 · 2025 · External reference

Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis

10.1080/09546634.2019.1612835 · 2020 · External reference

10.1001/jamadermatol.2022.3745

10.1001/jamadermatol.2022.3745 · External reference

Clinical course, antifungal susceptibility, and genomic sequencing of Trichophyton indotineae

10.1001/jamadermatol.2024.1126 · 2024 · External reference

10.1128/aac.01038‐18

10.1128/aac.01038‐18 · External reference

Autochthonous transmission of Trichophyton indotineae through sexual contact, France, 2024

10.2807/1560-7917.es.2025.30.26.2500416 · 2025 · External reference

Trichophyton indotineae: epidemiology, antifungal resistance and antifungal stewardship strategies

10.1111/jdv.20810 · 2026 · External reference

A prospective study on patterns of topical steroids self‐use in dermatophytoses and determinants predictive of cutaneous side effects

10.1111/dth.13633 · 2020 · External reference

10.1111/ced.15254

10.1111/ced.15254 · External reference

Re‐emerging role of KOH smear examination in the era of recalcirant dermatophytoses

10.1111/dth.14891 · 2021 · External reference

Spread of antifungal‐resistant Trichophyton indotineae, United Kingdom, 2017–2024

10.3201/eid3101.240923 · 2025 · External reference

Taxonomy of the Trichophyton mentagrophytes/T. interdigitale species complex harboring the highly virulent, multiresistant genotype T. indotineae

10.1007/s11046-021-00544-2 · 2021 · External reference

Identification of molds with matrix‐assisted laser desorption ionization‐time of flightmass spectrometry: performance of the newly developed MSI‐2 application in comparison with the Bruker filamentous fungi database and MSI‐1

10.1128/jcm.01299-21 · 2021 · External reference

Unresolved reference

2017 · External reference

How to: perform antifungal susceptibility testing of microconidia‐forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton

10.1016/j.cmi.2020.08.042 · 2021 · External reference

Rapid detection of terbinafine resistance in Trichophyton species by amplified refractory mutation system‐polymerase chain reaction

10.1038/s41598-020-58187-0 · 2020 · External reference

Unresolved reference

2021 · External reference

A unique multidrug‐resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: genomic insights and resistance profile

10.1016/j.fgb.2019.103266 · 2019 · External reference

Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force Against Recalcitrant Tinea (ITART) consensus on the Management of Glabrous Tinea (INTACT)

10.4103/idoj.idoj_233_20 · 2020 · External reference

Mutation in the squalene epoxidase gene of Trichophyton interdigitale and Trichophyton rubrum associated with allylamine resistance

10.1128/aac.02522-17 · 2018 · External reference

High terbinafine resistance in trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene

10.1111/myc.12772 · 2018 · External reference

Efficacy of terbinafine and itraconazole in different doses and in combination in the treatment of tinea infection: a randomized controlled parallel group open labeled trial with clinico‐mycological correlation

10.4103/ijd.ijd_548_19 · 2020 · External reference

Oral isotretinoin combined with oral terbinafine versus oral terbinafine alone to treat recurrent dermatophytosis: an open‐label randomised clinical trial

10.4103/idoj.idoj_167_21 · 2021 · External reference

Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)

10.1111/myc.13785 · 2024 · External reference

Pharmacokinetics of itraconazole following oral administration to normal volunteers

10.1128/aac.32.9.1310 · 1988 · External reference

Pharmacokinetic profile of orally administered itraconazole in human skin

10.1016/s0190-9622(88)70037-7 · 1988 · External reference

Pharmacokinetic and clinical comparison of super‐bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis

10.7573/dic.2022-8-1 · 2023 · External reference

Efficacy of super‐bioavailable itraconazole and conventional itraconazole at different dosing regimens in glabrous tinea infection – a randomized clinical trial

10.2147/dddt.s421583 · 2023 · External reference

IADVL SIG recalcitrant dermatophytosis position statement on super bioavailable itraconazole

10.4103/idoj.idoj_668_22 · 2024 · External reference

Super bioavailable itraconazole and its place and relevance in recalcitrant dermatophytosis: revisiting skin levels of itraconazole and minimum inhibitory concentration data

10.4103/idoj.idoj_618_20 · 2021 · External reference

Therapeutic updates on the management of tinea corporis or cruris in the era of Trichophyton indotineae: separating evidence from hype: a narrative review

10.4103/ijd.ijd_832_23 · 2023 · External reference

Multidrug resistant tinea corporis/cruris: response to voriconazole

10.1016/j.mycmed.2022.101306 · 2022 · External reference

Trichophyton indotineae extensive tinea: successful posaconazole treatment in four cases from Spain

10.1093/ced/llae417 · 2025 · External reference

Evaluation of the benefit of the addition of 1% topical luliconazole versus topical bland emollient to the systemic itraconazole therapy for the management of disseminated dermatophytosis: a randomised control trial

10.1111/myc.13681 · 2024 · External reference

Comparison between the efficacy of terbinafine and itraconazole orally vs. the combination of the two drugs in treating recalcitrant dermatophytosis

10.1038/s41598-023-46361-z · 2023 · External reference

In vitro antifungal combination of terbinafine with itraconazole against isolates of Trichophyton species

10.1128/aac.01449-21 · 2022 · External reference

Checkerboard analysis to evaluate synergistic combinations of existing antifungal drugs and propylene glycol monocaprylate in isolates from recalcitrant tinea corporis and cruris patients harboring squalene epoxidase gene mutation

10.1128/aac.00321-21 · 2021 · External reference

Scientific rationale of antifungal drug combination, including oral itraconazole and terbinafine, in recalcitrant dermatophytoses

10.1080/09546634.2019.1675857 · 2020 · External reference

Therapeutic outcomes in patients with Trichophyton indotineae: a systematic review and meta‐analysis of individual patient data

10.1111/myc.70048 · 2025 · External reference

Prolonged treatment of dermatophytosis caused by Trichophyton indotineae with terbinafine or itraconazole impacts better outcomes irrespective of mutation in the squalene epoxidase gene

10.1111/myc.13778 · 2024 · External reference

Comparing emollient use with topical luliconazole (azole) in the maintenance of remission of chronic and recurrent dermatophytosis. An open‐label, randomized prospective active‐controlled non‐inferiority study

10.1111/myc.13659 · 2024 · External reference

Relapse after oral terbinafine therapy in dermatophytosis: a clinical and mycological study

10.4103/0019-5154.190120 · 2016 · External reference

Real world analysis of response rate and efficacy of oral ketoconazole in patients with recalcitrant tinea corporis and cruris

10.4269/ajtmh.21-0505 · 2021 · External reference

Risk factors for chronic and chronic‐relapsing tinea corporis, tinea cruris and tinea faciei: results of a case‐control study

10.4103/ijdvl.ijdvl_807_17 · 2019 · External reference

Characterization of recalcitrant dermatophytosis in a multicenter study in Sri Lanka

10.4269/ajtmh.21-1022 · 2022 · External reference

Isotretinoin may affect pharmacokinetics of itraconazole in the skin: is it rational to combine both for the treatment of dermatophytosis?

10.4103/0378-6323.194292 · 2017 · External reference

Salicylic acid peeling in dermatophytosis: an unjustifiable therapy

10.25259/ijdvl_878_2021 · 2022 · External reference

Retrospective analysis of laboratory abnormalities in patients with preexisting liver and hematologic diseases prescribed terbinafine for onychomycosis

10.1016/j.jaad.2020.09.004 · 2021 · External reference

Clinical presentation of terbinafine‐induced severe liver injury and the value of laboratory monitoring: a critically appraised topic

10.1111/bjd.15854 · 2017 · External reference

10.1007/s10227‐001‐0048‐3

10.1007/s10227‐001‐0048‐3 · External reference

Evaluation of association between oral and topical terbinafine use in pregnancy and risk of major malformations and spontaneous abortion

10.1001/jamadermatol.2020.0142 · 2020 · External reference

Fetal outcomes after maternal exposure to oral antifungal agents during pregnancy: a systematic review and meta‐analysis

10.1002/ijgo.12993 · 2020 · External reference

Unresolved reference

2006 · External reference

Unresolved reference

2006 · External reference

Unresolved reference

2025 · External reference